SpyGlass Pharma, Inc. Common Stock (SGP) is a publicly traded the market company. As of November 5, 2026, SGP trades at $34.45 with a market cap of $1.15B and a P/E ratio of -43.34. SGP moved -0.22% today. Year to date, SGP is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $17.06 to $35.63. Analyst consensus is strong buy with an average price target of $39.33. Rallies surfaces SGP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
SGP financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. SGP recently traded at $34.45. Market cap is $1.15B. P/E ratio is -43.34. Revenue is $0.
| Metric | Value |
|---|---|
| Price | $34.45 |
| Market Cap | $1.15B |
| P/E Ratio | -43.34 |
| EPS | $-0.59 |
| Dividend Yield | 0.07% |
| 52-Week High | $35.63 |
| 52-Week Low | $17.06 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-19.86M |
| Gross Margin | 0.00% |
3 analysts cover SGP: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $39.33.